RC
XBIT icon

RBF Capital’s XBiotech XBIT Stock Holding History

RBF Capital’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Hold
198,501
– – 0.02% 400
2026
Q1 		$466K Hold
198,501
– – 0.02% 375
2025
Q4 		$474K Sell
198,501
-1,499
-0.7% -$3.69K 0.02% 408
2025
Q3 		$532K Hold
200,000
– – 0.02% 400
2025
Q2 		$594K Buy
+200,000
New +$581K 0.03% 397
2022
Q4 		– Sell
-23,172
Closed -$84K – 590
2022
Q3 		$84K Buy
+23,172
New +$109K 0.01% 502

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return

RBF Capital's XBIT Position: Q2 2026 in Review

RBF Capital held its XBiotech (XBIT) position steady in Q2 2026 at 198,501 shares worth $457K. The position accounts for 0.02% of the portfolio, ranked #400.

RBF Capital first reported a position in XBIT in Q3 2022 and has held it in 6 quarters since. The position peaked at $594K in Q2 2025. 36 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • RBF Capital held 198,501 shares of XBiotech worth $457K as of Q2 2026.
  • RBF Capital left its XBiotech share count unchanged in Q2 2026.
  • XBiotech made up 0.02% of RBF Capital's portfolio in Q2 2026, its #400 holding.
  • RBF Capital first reported a position in XBiotech in Q3 2022 and has held it in 6 quarters since.
  • RBF Capital's XBiotech position peaked at $594K in Q2 2025.
  • 36 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.